RNF151
gene geneOn this page
Summary
RNF151 (ring finger protein 151, HGNC:23235) is a protein-coding gene on chromosome 16p13.3, encoding RING finger protein 151 (Q2KHN1). May be involved in acrosome formation of spermatids.
Predicted to enable enzyme binding activity; identical protein binding activity; and zinc ion binding activity. Predicted to be involved in cell differentiation and spermatogenesis. Predicted to be located in cytoplasm and nucleus.
Source: NCBI Gene 146310 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 60 total
- MANE Select transcript:
NM_174903
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23235 |
| Approved symbol | RNF151 |
| Name | ring finger protein 151 |
| Location | 16p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000179580 |
| Ensembl biotype | protein_coding |
| Entrez | 146310 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000321392, ENST00000569210, ENST00000569714
RefSeq mRNA: 2 — MANE Select: NM_174903
NM_001348711, NM_174903
CCDS: CCDS58405, CCDS86495
Canonical transcript exons
ENST00000569714 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001262415 | 1967274 | 1967419 |
| ENSE00001262441 | 1967725 | 1967821 |
| ENSE00002584221 | 1966856 | 1966884 |
| ENSE00003842786 | 1968434 | 1968949 |
Expression profiles
Bgee: expression breadth broad, 94 present calls, max score 97.49.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1234 / max 166.4504, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 152147 | 0.1234 | 3 |
Top tissues by expression
212 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 97.49 | gold quality |
| right testis | UBERON:0004534 | 97.46 | gold quality |
| testis | UBERON:0000473 | 93.80 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.98 | gold quality |
| sperm | CL:0000019 | 86.35 | silver quality |
| adult organism | UBERON:0007023 | 79.17 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 76.83 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 76.68 | gold quality |
| myocardium | UBERON:0002349 | 74.83 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 71.42 | gold quality |
| biceps brachii | UBERON:0001507 | 70.84 | gold quality |
| cartilage tissue | UBERON:0002418 | 69.31 | gold quality |
| pancreatic ductal cell | CL:0002079 | 65.43 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 64.59 | gold quality |
| deltoid | UBERON:0001476 | 63.89 | gold quality |
| upper arm skin | UBERON:0004263 | 63.39 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 63.31 | gold quality |
| quadriceps femoris | UBERON:0001377 | 63.06 | gold quality |
| vastus lateralis | UBERON:0001379 | 62.48 | gold quality |
| vena cava | UBERON:0004087 | 61.88 | gold quality |
| parotid gland | UBERON:0001831 | 61.62 | gold quality |
| endothelial cell | CL:0000115 | 61.38 | gold quality |
| decidua | UBERON:0002450 | 60.30 | gold quality |
| jejunal mucosa | UBERON:0000399 | 58.13 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 57.95 | gold quality |
| pons | UBERON:0000988 | 57.86 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 57.84 | gold quality |
| muscle tissue | UBERON:0002385 | 57.81 | gold quality |
| tibialis anterior | UBERON:0001385 | 56.50 | silver quality |
| jejunum | UBERON:0002115 | 56.49 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 1786.49 |
| E-ANND-3 | no | 1.78 |
Regulation
Is transcription factor: no
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rnf151 | ENSDARG00000075046 |
| mus_musculus | Rnf151 | ENSMUSG00000008482 |
| rattus_norvegicus | Rnf151 | ENSRNOG00000014127 |
| drosophila_melanogaster | CG9014 | FBGN0028847 |
Paralogs (1): RNF41 (ENSG00000181852)
Protein
Protein identifiers
RING finger protein 151 — Q2KHN1 (reviewed: Q2KHN1)
All UniProt accessions (3): A0A0C4DFQ4, Q2KHN1, H3BNJ8
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in acrosome formation of spermatids.
Subunit / interactions. Interacts with DTNBP1.
Subcellular location. Cytoplasm. Nucleus.
Tissue specificity. Expression is testis-specific.
RefSeq proteins (2): NP_001335640, NP_777563* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001293 | Znf_TRAF | Domain |
| IPR001841 | Znf_RING | Domain |
| IPR013010 | Znf_SIAH | Domain |
| IPR013083 | Znf_RING/FYVE/PHD | Homologous_superfamily |
| IPR017907 | Znf_RING_CS | Conserved_site |
Pfam: PF13923
UniProt features (4 total): zinc finger region 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q2KHN1-F1 | 87.48 | 0.71 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 38 (showing top):
WHITEHURST_PACLITAXEL_SENSITIVITY, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_MALE_GAMETE_GENERATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_PROTEIN_CATABOLIC_PROCESS, IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM, GOBP_PROTEOLYSIS, NIKOLSKY_BREAST_CANCER_16P13_AMPLICON, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY, MIKKELSEN_MCV6_LCP_WITH_H3K4ME3, MIKKELSEN_IPS_LCP_WITH_H3K4ME3, MIKKELSEN_ES_LCP_WITH_H3K4ME3, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
GO Biological Process (2): spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (5): zinc ion binding (GO:0008270), enzyme binding (GO:0019899), identical protein binding (GO:0042802), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein binding | 2 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
695 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RNF151 | RNF133 | Q8WVZ7 | 554 |
| RNF151 | BRICD5 | Q6PL45 | 519 |
| RNF151 | RNF126 | Q9BV68 | 502 |
| RNF151 | RNF175 | Q8N4F7 | 489 |
| RNF151 | A0A2R8Y4M4 | A0A2R8Y4M4 | 479 |
| RNF151 | SH2D7 | A6NKC9 | 474 |
| RNF151 | METTL24 | Q5JXM2 | 474 |
| RNF151 | RBM18 | Q96H35 | 451 |
| RNF151 | FAHD1 | Q6P587 | 437 |
| RNF151 | OR2B11 | Q5JQS5 | 434 |
| RNF151 | PAMR1 | Q6UXH9 | 434 |
| RNF151 | OR5I1 | Q13606 | 422 |
| RNF151 | SHCBP1L | Q9BZQ2 | 418 |
| RNF151 | CBLL2 | Q8N7E2 | 417 |
| RNF151 | RNF148 | Q8N7C7 | 405 |
IntAct
54 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RNF151 | SREK1IP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF151 | CT45A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRPF3 | RNF151 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF151 | TSPYL2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF151 | NKAPD1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF151 | DVL3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF151 | ABT1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF151 | MMTAG2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF151 | PIBF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FGF12 | RNF151 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF151 | FAM133A | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF151 | FAM9A | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF151 | SCARA5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF151 | UBE2I | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF151 | ZC4H2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF151 | psi-mi:“MI:0914”(association) | 0.350 | |
| RNF151 | TNRC18 | psi-mi:“MI:0914”(association) | 0.350 |
| RNF151 | MMAB | psi-mi:“MI:0914”(association) | 0.350 |
| SREK1IP1 | RNF151 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RNF151 | CT45A1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PRPF3 | RNF151 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RNF151 | TSPYL2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RNF151 | FAM133A | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (127): DTNBP1 (Reconstituted Complex), RNF151 (Reconstituted Complex), DTNBP1 (Affinity Capture-Western), DTNBP1 (Co-localization), RNF151 (Two-hybrid), RNF151 (Two-hybrid), RNF151 (Two-hybrid), RNF151 (Two-hybrid), RNF151 (Two-hybrid), RNF151 (Two-hybrid), RNF151 (Two-hybrid), RNF151 (Two-hybrid), RNF151 (Two-hybrid), RNF151 (Two-hybrid), RNF151 (Two-hybrid)
ESM2 similar proteins: D3YY23, G5E8P1, O43255, O43900, O60260, O94953, O95696, P25066, P25456, P90489, Q06986, Q08DF2, Q13049, Q17RB8, Q2KHN1, Q2TBT8, Q3V1N1, Q4TVR5, Q4U5R4, Q5FWL3, Q5M974, Q5R7T5, Q5REG4, Q5XIL0, Q6GPV5, Q6J1I8, Q6J212, Q6J2U6, Q7KTX7, Q7ZW16, Q80V91, Q80VI1, Q80VL3, Q8BH75, Q8CH72, Q8N9I9, Q8R4T2, Q8T3Y0, Q91VY5, Q91XF4
Diamond homologs: A0A1L8FG46, A0A1L8FM16, B1AUE5, E7FDW2, O35445, O60683, O64425, P68907, P87176, Q09463, Q2KHN1, Q2TBT8, Q54S31, Q568Y3, Q5M807, Q5RFK9, Q5ZIR9, Q69ZS0, Q6PC78, Q8HXW8, Q91YT2, Q96GF1, Q99942, Q9P3U8, Q9SYU4, Q9UPQ7, Q9UUF0, Q9V8P9, A8WWR3, O22197, O22283, O60106, P30631, P90859, Q07G42, Q0II22, Q641J8, Q6AVN2, Q6DIP3, Q6IRP0
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| Ub:E2 | “up-regulates activity” | RNF151 | ubiquitination |
Disease & clinical
Clinical variants and AI predictions
ClinVar
60 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 51 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
469 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:1968432:A:AG | acceptor_gain | 1.0000 |
| 16:1968433:G:GG | acceptor_gain | 1.0000 |
| 16:1967813:G:GT | donor_gain | 0.9900 |
| 16:1968432:A:G | acceptor_loss | 0.9900 |
| 16:1968433:GT:G | acceptor_gain | 0.9900 |
| 16:1966958:G:T | donor_gain | 0.9800 |
| 16:1966979:A:T | donor_gain | 0.9800 |
| 16:1967058:GC:G | donor_gain | 0.9800 |
| 16:1967817:TCAAG:T | donor_loss | 0.9800 |
| 16:1967819:AAGG:A | donor_loss | 0.9800 |
| 16:1967820:AGGTA:A | donor_loss | 0.9800 |
| 16:1967821:GGTA:G | donor_loss | 0.9800 |
| 16:1967823:T:C | donor_loss | 0.9800 |
| 16:1967832:G:GG | donor_gain | 0.9800 |
| 16:1968433:GTGCA:G | acceptor_gain | 0.9800 |
| 16:1967410:G:GA | donor_gain | 0.9700 |
| 16:1967412:C:G | donor_gain | 0.9700 |
| 16:1967723:A:AG | acceptor_gain | 0.9700 |
| 16:1967724:G:GG | acceptor_gain | 0.9700 |
| 16:1968432:AGT:A | acceptor_gain | 0.9700 |
| 16:1968433:GTG:G | acceptor_gain | 0.9700 |
| 16:1968433:GTGC:G | acceptor_gain | 0.9700 |
| 16:1966982:GG:G | donor_gain | 0.9500 |
| 16:1966983:GG:G | donor_gain | 0.9500 |
| 16:1967426:GCGG:G | donor_gain | 0.9500 |
| 16:1967724:GA:G | acceptor_gain | 0.9500 |
| 16:1967724:GAC:G | acceptor_gain | 0.9400 |
| 16:1967724:GACA:G | acceptor_gain | 0.9400 |
| 16:1967041:GC:G | donor_gain | 0.9300 |
| 16:1967367:T:TA | donor_gain | 0.9300 |
AlphaMissense
1591 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:1967385:T:C | F39L | 0.991 |
| 16:1967387:C:A | F39L | 0.991 |
| 16:1967387:C:G | F39L | 0.991 |
| 16:1967298:T:C | F10L | 0.987 |
| 16:1967300:C:A | F10L | 0.987 |
| 16:1967300:C:G | F10L | 0.987 |
| 16:1968434:T:A | C83S | 0.975 |
| 16:1968435:G:C | C83S | 0.975 |
| 16:1968455:T:A | C90S | 0.974 |
| 16:1968456:G:C | C90S | 0.974 |
| 16:1967337:T:A | C23S | 0.969 |
| 16:1967338:G:C | C23S | 0.969 |
| 16:1967381:C:A | H37Q | 0.964 |
| 16:1967381:C:G | H37Q | 0.964 |
| 16:1967328:T:C | C20R | 0.963 |
| 16:1967389:G:A | C40Y | 0.963 |
| 16:1967397:T:A | C43S | 0.962 |
| 16:1967398:G:C | C43S | 0.962 |
| 16:1967388:T:A | C40S | 0.961 |
| 16:1967389:G:C | C40S | 0.961 |
| 16:1967299:T:G | F10C | 0.960 |
| 16:1967386:T:C | F39S | 0.960 |
| 16:1967299:T:C | F10S | 0.959 |
| 16:1967335:T:A | V22D | 0.959 |
| 16:1967739:C:A | P55Q | 0.959 |
| 16:1968434:T:C | C83R | 0.959 |
| 16:1967386:T:G | F39C | 0.957 |
| 16:1967328:T:A | C20S | 0.955 |
| 16:1967329:G:C | C20S | 0.955 |
| 16:1967337:T:C | C23R | 0.954 |
dbSNP variants (sampled 300 via entrez): RS1001374265 (16:1968737 C>T), RS1001591131 (16:1966634 G>T), RS1002649697 (16:1967572 A>G), RS1003605698 (16:1968716 C>A,T), RS1003656798 (16:1968621 G>A,T), RS1003786438 (16:1964877 T>A), RS1003892482 (16:1965717 C>T), RS1004409488 (16:1965811 G>A), RS1005302265 (16:1966692 C>A,T), RS1005406639 (16:1968291 C>A,T), RS1006405281 (16:1968076 C>T), RS1007888531 (16:1967024 CCTT>C), RS1008325581 (16:1966796 G>A), RS1008348203 (16:1965097 C>G,T), RS1008796877 (16:1969160 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010796_5218 | Electrocardiogram morphology (amplitude at temporal datapoints) | 2.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004327 | electrocardiography |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| 3,4,5,3’,4’-pentachlorobiphenyl | decreases expression | 1 |
| Smoke | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.